Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry)
Open Access
- 8 September 2022
- journal article
- research article
- Published by Silicea - Poligraf in Rational Pharmacotherapy in Cardiology
- Vol. 18 (4), 449-454
- https://doi.org/10.20996/1819-6446-2022-08-12
Abstract
Aim. To study the frequency of detection of hyperuricemia (HU) in patients with high and very high cardiovascular risk and the frequency of prescribing drugs that lower serum uric acid (sUA) levels in real clinical practice. Material and methods: The general information of the study was based on the data of 2457 patients who were consistently included in the «PROFILE» registry until November 30, 2020: 1250 men (50.9%) and 1207 (49.1%) women. All patients with HU were selected (UA level ≥360 pmol/l in women, ≥420 pmol/l in men). At the stage of inclusion of the patient, data on MC indicators were available in 1777 (72.3%), upon re-examination - only 262 (33.2%) out of 790 patients who returned to the appointment. Results: The most common study of the level of sUA was performed in patients with gout (65.2%), with arterial hypertension (AH) and dyslipemia in 29.1% of cases, with diabetes mellitus (DM) - 30.1%, with impaired tolerance to glucose (IGT) - 40.2%, with other diseases, the proportion of patients with a known UA was even less. A positive relationship was found between the presence of AH and IGT with the frequency of UA control (pConclusion: in real clinical practice, only 29.1% of patients with AH and 20-25% of patients with other CVDs were monitored for sUA levels, every third patient had data on sUA levels at a repeat visit. In the presence of gout, the proportion of patients with current UA was higher (65%). For those with AH and IGT, positive correlations were found between the presence of the disease and control of sUA levels. A low frequency of prescribing drugs for the correction of HU was revealed.Keywords
This publication has 20 references indexed in Scilit:
- Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular riskCardiology Journal, 2018
- 2018 ESC/ESH Guidelines for the management of arterial hypertensionJournal of Hypertension, 2018
- Allopurinol Overuse in Asymptomatic HyperuricemiaJAMA Internal Medicine, 2014
- HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY)Rational Pharmacotherapy in Cardiology, 2014
- Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortalityQJM: An International Journal of Medicine, 2013
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged MenArchives of Internal Medicine, 2004
- Serum Uric Acid and Cardiovascular MortalityJAMA, 2000
- Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart StudyAnnals of Internal Medicine, 1999